{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T20:26:55Z","timestamp":1764793615527},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Science Inc"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s11906-008-0013-2","type":"journal-article","created":{"date-parts":[[2008,2,6]],"date-time":"2008-02-06T21:06:46Z","timestamp":1202332006000},"page":"65-69","source":"Crossref","is-referenced-by-count":25,"title":["Endothelin-1 and hypertension: From bench to bedside"],"prefix":"10.1007","volume":"10","author":[{"given":"Donald E.","family":"Kohan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,2,7]]},"reference":[{"key":"13_CR1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.2005.02503.x","volume":"60","author":"N. Dhaun","year":"2005","unstructured":"Dhaun N, Strachan FE, Newby DE, et al.: Vasodilator effects of the endothelin ET receptor selective antagonist BMS-193884 in healthy men. Br J Clin Pharmacol 2005, 60:611\u2013622.","journal-title":"Br J Clin Pharmacol"},{"key":"13_CR2","first-page":"653","volume":"231","author":"B. Battistini","year":"2006","unstructured":"Battistini B, Berthiaume N, Kelland N, et al.: Profile of past and current clinical trials involving endothelin receptor antagonists: the novel \u201c-sentan\u201d class of drug. Exp Biol Med (Maywood) 2006, 231:653\u2013695.","journal-title":"Exp Biol Med (Maywood)"},{"key":"13_CR3","doi-asserted-by":"crossref","first-page":"H2554","DOI":"10.1152\/ajpheart.01221.2005","volume":"290","author":"R.M. Fryer","year":"2006","unstructured":"Fryer RM, Rakestraw PA, Banfor PN, et al.: Blood pressure regulation by ETA and ETB receptors in conscious, telemetry-instrumented mice and role of ETA in hypertension produced by selective ETB blockade. Am J Physiol Heart Circ Physiol 2006, 290:H2554\u2013H2559.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"13_CR4","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1161\/01.HYP.0000161878.81141.62","volume":"45","author":"M. Ohkita","year":"2005","unstructured":"Ohkita M, Wang Y, Nguyen ND, et al.: Extrarenal ETB plays a significant role in controlling cardiovascular responses to high dietary sodium in rats. Hypertension 2005, 45:940\u2013946.","journal-title":"Hypertension"},{"key":"13_CR5","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.hjh.0000166838.55688.7e","volume":"23","author":"T. Quaschning","year":"2005","unstructured":"Quaschning T, Rebhan B, Wunderlich C, et al.: Endothelin B receptor-deficient mice develop endothelial dysfunction independently of salt loading. J Hypertens 2005, 23:979\u2013985.","journal-title":"J Hypertens"},{"key":"13_CR6","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1161\/01.HYP.0000229907.58470.4c","volume":"48","author":"A.J. Bagnall","year":"2006","unstructured":"Bagnall AJ, Kelland NF, Gulliver-Sloan F, et al.: Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 2006, 48:286\u2013293.","journal-title":"Hypertension"},{"key":"13_CR7","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.pharmthera.2005.11.001","volume":"111","author":"F. Brunner","year":"2006","unstructured":"Brunner F, Bras-Silva C, Cerdeira AS, et al.: Cardiovascular endothelins: Essential regulators of cardiovascular homeostasis. Pharmacol Ther 2006, 111:508\u2013531.","journal-title":"Pharmacol Ther"},{"key":"13_CR8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/01.mnh.0000186852.15889.1a","volume":"15","author":"D.E. Kohan","year":"2006","unstructured":"Kohan DE: The renal medullary endothelin system in control of sodium and water excretion and systemic blood pressure. Curr Opin Nephrol Hypertens 2006, 15:34\u201340.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"13_CR9","first-page":"1001","volume":"231","author":"X. Guo","year":"2006","unstructured":"Guo X, Yang T: Endothelin B receptor antagonism in the rat renal medulla reduces urine flow rate and sodium excretion. Exp Biol Med (Maywood) 2006, 231:1001\u20131005.","journal-title":"Exp Biol Med (Maywood)"},{"key":"13_CR10","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1172\/JCI200421064","volume":"114","author":"D. Ahn","year":"2004","unstructured":"Ahn D, Ge Y, Stricklett P, et al.: Collecting duct-specific knockout of endothelin-1 causes hypertension and sodium retention. J Clin Invest 2004, 114:504\u2013511.","journal-title":"J Clin Invest"},{"key":"13_CR11","first-page":"F692","volume":"289","author":"Y. Ge","year":"2005","unstructured":"Ge Y, Stricklett P, Hughes A, et al.: Effect of collecting duct-specific knockout of the endothelin A receptor on salt and water metabolism. Am J Physiol 2005, 289:F692\u2013F698.","journal-title":"Am J Physiol"},{"key":"13_CR12","first-page":"F1274","volume":"291","author":"Y. Ge","year":"2006","unstructured":"Ge Y, Bagnall A, Stricklett P, et al.: Collecting duct-specific knockout of the endothelin B receptor causes hypertension and sodium retention. Am J Physiol, 2006, 291:F1274\u20131280.","journal-title":"Am J Physiol"},{"key":"13_CR13","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1097\/00005344-200000002-00008","volume":"35","author":"E.L. Schiffrin","year":"2000","unstructured":"Schiffrin EL: Endothelin: role in experimental hypertension. J Cardiovasc Pharmacol 2000, 35:S33\u2013S35.","journal-title":"J Cardiovasc Pharmacol"},{"key":"13_CR14","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1161\/01.HYP.0000173426.06832.b5","volume":"46","author":"I. Vaneckova","year":"2005","unstructured":"Vaneckova I, Kramer HJ, Backer A, et al.: Early endothelin-A receptor blockade decreases blood pressure and ameliorates end-organ damage in homozygous Ren-2 rats. Hypertension 2005, 46:969\u2013974.","journal-title":"Hypertension"},{"key":"13_CR15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1161\/01.CIR.0000118499.69469.51","volume":"109","author":"J. Goddard","year":"2004","unstructured":"Goddard J, Johnston NR, Hand MF, et al.: Endothelin-A receptor antagonism reduces blood pressure and increases renal blood flow in hypertensive patients with chronic renal failure: a comparison of selective and combined endothelin receptor blockade. Circulation 2004, 109:1186\u20131193.","journal-title":"Circulation"},{"key":"13_CR16","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1161\/01.HYP.33.2.753","volume":"33","author":"C. Cardillo","year":"1999","unstructured":"Cardillo C, Kilcoyne CM, Waclawiw M, et al.: Role of endothelin in the increased vascular tone of patients with essential hypertension. Hypertension 1999, 33:753\u2013758.","journal-title":"Hypertension"},{"key":"13_CR17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/1568006054553390","volume":"5","author":"R.C. Tostes","year":"2005","unstructured":"Tostes RC, Muscara MN: Endothelin receptor antagonists: another potential alternative for cardiovascular diseases. Curr Drug Targets Cardiovasc Haematol Disord 2005, 5:287\u2013301.","journal-title":"Curr Drug Targets Cardiovasc Haematol Disord"},{"key":"13_CR18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1042\/CS20050359","volume":"110","author":"D.M. Pollock","year":"2006","unstructured":"Pollock DM: How does endothelin induce vascular oxidative stress in mineralocorticoid hypertension? Clin Sci (Lond) 2006, 110:205\u2013206.","journal-title":"Clin Sci (Lond)"},{"key":"13_CR19","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20050307","volume":"110","author":"G.E. Callera","year":"2006","unstructured":"Callera GE, Tostes RC, Yogi A, et al.: Endothelin-1-induced oxidative stress in DOCA-salt hypertension involves NADPH-oxidase-independent mechanisms. Clin Sci (Lond) 2006, 110:243\u2013253.","journal-title":"Clin Sci (Lond)"},{"key":"13_CR20","first-page":"152","volume":"16","author":"Z. Abassi","year":"2001","unstructured":"Abassi Z, Ellahham S, Winaver J, et al.: The intrarenal endothelin system and hypertension. News Physiol Sci 2001, 16:152\u2013156.","journal-title":"News Physiol Sci"},{"key":"13_CR21","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1523-1755.2004.00483.x","volume":"65","author":"R. Girchev","year":"2004","unstructured":"Girchev R, Backer A, Markova P, et al.: Impaired response of the denervated kidney to endothelin receptor blockade in normotensive and spontaneously hypertensive rats. Kidney Int 2004, 65:982\u2013989.","journal-title":"Kidney Int"},{"key":"13_CR22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/01.HYP.20.5.666","volume":"20","author":"A.K. Hughes","year":"1992","unstructured":"Hughes AK, Cline RC, Kohan DE: Alterations in renal endothelin production in the spontaneously hypertensive rat. Hypertension 1992, 20:666\u2013673.","journal-title":"Hypertension"},{"key":"13_CR23","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/ki.1994.72","volume":"45","author":"A. Hoffman","year":"1993","unstructured":"Hoffman A, Grossman E, Goldstein DS, et al.: Urinary excretion rate of endothelin-1 in patients with essential hypertension and salt sensitivity. Kidney Int 1993, 45:556\u2013560.","journal-title":"Kidney Int"},{"key":"13_CR24","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0895-7061(98)00170-8","volume":"11","author":"Y.S. Hwang","year":"1998","unstructured":"Hwang YS, Hsieh TJ, Lee YJ, et al.: Circadian rhythm of urinary endothelin-1 excretion in mild hypertensive patients. Am J Hypertens 1998, 11:1344\u20131351.","journal-title":"Am J Hypertens"},{"key":"13_CR25","first-page":"1320","volume":"10","author":"C. Zoccali","year":"1995","unstructured":"Zoccali C, Leonardis D, Parlongo S, et al.: Urinary and plasma endothelin 1 in essential hypertension and in hypertension secondary to renoparenchymal disease. Nephrol Dial Transplant 1995, 10:1320\u20131323.","journal-title":"Nephrol Dial Transplant"},{"issue":"Suppl3","key":"13_CR26","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1097\/00005344-199526003-00004","volume":"26","author":"P.A. Stevens","year":"1995","unstructured":"Stevens PA, Brown MJ: Genetic variability of the ET-1 and the ETA receptor genes in essential hypertension. J Cardiovasc Pharmacol 1995, 26(Suppl 3):S9\u2013S12.","journal-title":"J Cardiovasc Pharmacol"},{"key":"13_CR27","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1161\/hy1101.095333","volume":"38","author":"T. Asai","year":"2001","unstructured":"Asai T, Ohkubo T, Katsuya T, et al.: Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001, 38:1321\u20131324.","journal-title":"Hypertension"},{"key":"13_CR28","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/01.HYP.0000043680.75107.CF","volume":"41","author":"J.J. Jin","year":"2003","unstructured":"Jin JJ, Nakura J, Wu Z, et al.: Association of endothelin-1 gene variant with hypertension. Hypertension 2003, 41:163\u2013167.","journal-title":"Hypertension"},{"key":"13_CR29","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.HYP.33.5.1169","volume":"33","author":"L. Tiret","year":"1999","unstructured":"Tiret L, Poirier O, Hallet V, et al.: The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999, 33:1169\u20131174.","journal-title":"Hypertension"},{"key":"13_CR30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/clc.4960270510","volume":"27","author":"P. Hallberg","year":"2004","unstructured":"Hallberg P, Karlsson J, Lind L, et al.: Gender-specific association between preproendothelin-1 genotype and reduction of systolic blood pressure during antihypertensive treatment\u2014results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA). Clin Cardiol 2004, 27:287\u2013290.","journal-title":"Clin Cardiol"},{"key":"13_CR31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1097\/01.hjh.0000184748.49189.36","volume":"23","author":"O. Ormezzano","year":"2005","unstructured":"Ormezzano O, Poirier O, Mallion JM, et al.: A polymorphism in the endothelin-A receptor gene is linked to baroreflex sensitivity. J Hypertens 2005, 23:2019\u20132026.","journal-title":"J Hypertens"},{"key":"13_CR32","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.HYP.0000217520.44176.73","volume":"47","author":"M. Iemitsu","year":"2006","unstructured":"Iemitsu M, Maeda S, Otsuki T, et al.: Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older subjects. Hypertension 2006, 47:928\u2013936.","journal-title":"Hypertension"},{"key":"13_CR33","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJM199803193381202","volume":"338","author":"H. Krum","year":"1998","unstructured":"Krum H, Viskoper RJ, Lacourciere Y, et al.: The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators. N Engl J Med 1998, 338:784\u2013790.","journal-title":"N Engl J Med"},{"key":"13_CR34","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0895-7061(02)02933-3","volume":"15","author":"R. Nakov","year":"2002","unstructured":"Nakov R, Pfarr E, Eberle S: Darusentan: an effective endothelin A receptor antagonist for treatment of hypertension. Am J Hypertens 2002, 15:583\u2013589.","journal-title":"Am J Hypertens"},{"key":"13_CR35","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1681\/ASN.2005121256","volume":"17","author":"N. Dhaun","year":"2006","unstructured":"Dhaun N, Goddard J, Webb DJ: The endothelin system and its antagonism in chronic kidney disease. J Am Soc Nephrol 2006, 17:943\u2013955.","journal-title":"J Am Soc Nephrol"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-008-0013-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-008-0013-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-008-0013-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:14:20Z","timestamp":1559434460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-008-0013-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["13"],"URL":"https:\/\/doi.org\/10.1007\/s11906-008-0013-2","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}